Monthly brand intelligence
Track the UK aesthetics brands clinics actually show.
Brand visibility, treatment adoption, distributor-route and KOL signal reports for injectable, skincare, device, regenerative and Korean aesthetic categories.
Narrow reports buyers already search for.
Each report can be published as a short public snapshot, with the full table, clinic segments, regional cuts and route-to-market implications available by request.
Injectable brand visibility
HA fillers, botulinum toxin, biostimulators and adjacent injectable brands tracked against clinic visibility, treatment pages, category language and price context.
Korean brand UK visibility
Korean aesthetic manufacturers assessed by clinic presence, distributor route, training evidence, category fit, professional credibility and launch-risk signals.
Polynucleotide and skin booster tracker
Category adoption, clinic language, competing products, regenerative-treatment framing, pricing signals and educator routes.
Device and laser signal reports
Installed-base signals from clinic websites, brand locators and treatment menus, with device-led clinic segments and regional opportunity cuts.
What gets measured.
Indexeli reports are built from primary market evidence, not respondent panels. The output is designed for brand teams, distributors, investors and overseas manufacturers deciding where a category is moving.
Clinic visibility
Brand mentions, treatment menus, pricing pages, product language, clinic type, geography, contact route, web presence and adoption signals.
Commercial route
Distributor links, portfolio conflicts, training routes, academy evidence, premium versus discount signals and likely channel risk.
Influence and readiness
KOL and educator pathways, advisor needs, claims and evidence gaps, launch timing, category maturity and segment-specific adoption barriers.
What's in each monthly issue.
A category subscription is a structured issue built from that month's primary capture — the same spine every issue, so movement is comparable month to month.
Visibility index
Category and product visibility across the clinic base — what surfaces, where, and how it moved against the prior issue.
Price and positioning context
Where the category sits in the national and regional UK pricing distribution, with premium-versus-discount framing drawn from source pages.
Route and KOL signals
Distributor-route and portfolio-fit signals, plus educator and KOL pathways relevant to the category that month.
Movers
New, lapsed and fast-moving clinic signals versus the prior issue — the month-on-month diff that shows direction, not just a snapshot.
Regional cuts
Category visibility and pricing by UK region, with the segment splits that matter for where a launch lands first.
Readout
A short written read on what changed and what it implies for launch, positioning or portfolio decisions in the category.
Data spine.
The public report layer sits on the same source-captured datasets used for UK market-entry readouts, distributor analysis and data-only extracts.
Three ways to take it.
The same monthly evidence, packaged for how you need it — from a public snapshot to a recurring category subscription to a bespoke readout.
Public snapshot
A short, openly published read on a category's direction and competitive picture — a way to see how the evidence reads before you commit.
Monthly subscription
A new issue for one category each month — the full visibility index, pricing context, regional cuts, movers and written readout, built to be compared issue to issue.
Bespoke readout
A private, deeper cut for a specific launch, transaction or portfolio question — clinic lists, distributor context, advisor needs and a UK entry recommendation.
See it first. Ask for the specimen issue — a worked example of a full monthly category report — before you subscribe. Request the specimen issue.
Useful, but deliberately limited.
Brand visibility is not the same as revenue, prescribing, procedure volume or sell-through. The value is that it shows where brands are publicly visible, which clinics surface them, how categories are described and which commercial routes appear credible.
Best use: use the public snapshot to understand direction and competitors, then request the full cut when you need clinic lists, regional splits, distributor context, advisor needs or a UK entry recommendation.
Request a category cut.
Send the category, brand set or launch question. Indexeli can scope a public snapshot, a private full report, or a pre-distributor UK market-entry readout.
For manufacturers
Understand UK category maturity, competitor visibility, distributor route quality, clinic fit and evidence gaps before committing launch spend.
Request manufacturer readoutFor distributors and investors
Benchmark brand visibility, find whitespace, assess category growth signals and test whether a portfolio has credible clinic-facing traction.
Request category reportRelated routes.
Brand intelligence is one entry point into the wider Indexeli market-entry evidence base.